Matt, Author at European Medical Journal - Page 101 of 212

Continue
1 Mins
1 Aug 2019

Post-Transplant Cyclophosphamide in HLA Matched and Haploidentical Transplant Recipients Receiving Myeloablative Timed Sequential Busulfan Conditioning Regimen: Results of a Phase II Study

The authors report a prospective Phase II trial to assess (a) if post-transplant cyclophosphamide (PTCy) could be safely incorporated in a timed…
12 Mins
1 Aug 2019

EHA 2019 Interviews

Find out more about about the EHA Congress through our interviews with members of the various committees required to help…
3 Mins
1 Aug 2019

Umbilical Cord Blood Donation: An Evolving Lifeline for the Stem Cell Field

Cord blood can be collected and stored from the placenta and umbilical cord following the birth of a new-born. It is replete with haematopoietic stem…
1 Mins
1 Aug 2019

Autologous Dendritic Cell Vaccination to Prevent Progression and Relapse in Multiple Myeloma

Data from the National Cancer Institute showed that 50% of myeloma patients survive past 5 years post-diagnosis. This is encouraging but also warns…
5 Mins
1 Aug 2019

Editor’s Pick: New Insights in β-Thalassaemia

Thalassaemia is a hereditary cause of hypochromic microcytic anaemia resulting from defects in haemoglobin (Hb) production…
2 Mins
1 Aug 2019

Gilteritinib Plus Azacitidine in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukaemia Patients Ineligible for Intensive Induction Chemotherapy: Preliminary Findings from the Safety Cohort

Search of more effective treatment for patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy remains challenging…
6 Mins
1 Aug 2019

Retrospective Review of the Role of Abdominal Imaging in Evaluation of Cytopenias

Specifically, this study examines the use of abdominal imaging, via an ultrasound or CT scan, to identify the aetiology of haematologic abnormalities…
9 Mins
1 Aug 2019

Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder that lessens the production of platelets. Despite treatments being available for ITP…
5 Mins
1 Aug 2019

Resistant Bilateral Chylous Effusion as a Late Adverse Effect of Dasatinib Treatment in Chronic Myeloid Leukaemia

Dasatinib is a potent and efficacious second-generation oral tyrosine kinase inhibitor, frequently used for imatinib-resistant or intolerant BCR-ABL+…
5 Mins
1 Aug 2019

Are Successful Pregnancies an Achievable Goal in Patients with Chronic Myeloid Leukaemia?

Currently, there is no evidence-based consensus for the management of CML in pregnancy; therefore, clinical observations have become very important…
We’ve noticed you’re accessing
from North/South America.